Changes in adults' vaping and smoking behaviours associated with aerosol-free laws.


Journal

Tobacco control
ISSN: 1468-3318
Titre abrégé: Tob Control
Pays: England
ID NLM: 9209612

Informations de publication

Date de publication:
11 2021
Historique:
received: 17 02 2020
revised: 13 07 2020
accepted: 04 08 2020
pubmed: 17 9 2020
medline: 15 12 2021
entrez: 16 9 2020
Statut: ppublish

Résumé

Banning e-cigarette use in public places has attracted considerable debate, with governments adopting different policies. However, little is known about the outcomes of such bans. We investigated the association of banning e-cigarette use in public places and workplaces in Canadian provinces with adults' vaping and smoking behaviours. Difference-in-differences. Nationally representative Canadian Tobacco Use Monitoring Survey (CTUMS) and Canadian Tobacco, Alcohol and Drugs Survey (CTADS). Adults aged 19 and older from CTADS 2013-2017 for e-cigarette outcomes (N=36 562) and from CTUMS/CTADS 2004-2017 for combustible cigarette outcomes (N=178 654). Bans on e-cigarette use in public places and workplaces in Canadian provinces. Past 30-day e-cigarette use, current combustible cigarette use, use of e-cigarettes when unable to smoke combustible cigarettes. After the bans, e-cigarette use in the past 30 days did not change significantly in provinces with a ban compared with provinces without a ban (0.004; 95% CI -0.025 to 0.032; p=0.783). The bans also had no impact on current combustible cigarette use (0.009; 95% CI -0.019 to 0.037; p=0.488). There is evidence of ban evasion among young people aged 19-24 who, after the bans, reported higher use of e-cigarettes when unable to smoke combustible cigarettes (0.114; 95% CI -0.023 to 0.250; p=0.092). Two years after implementation, the aerosol-free laws in Canada had no impacton adults' vaping and smoking behaviours. Policy efforts are urgently needed to improve the ban enforcement and to deal with discreet vaping among young adults.

Identifiants

pubmed: 32934091
pii: tobaccocontrol-2020-055705
doi: 10.1136/tobaccocontrol-2020-055705
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

644-652

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Hai V Nguyen (HV)

School of Pharmacy, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada hvnguyen@mun.ca.

Stephen Bornstein (S)

Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada.
Director, Newfoundland and Labrador Centre for Applied Health Research, St. John's, Newfoundland and Labrador, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH